ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,287Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 1111

$1.02M Total Retail Price of All Prescriptions

Rank: 38 out of 1111

519 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 14,021 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 723 507 S3 1 1
FUROSEMIDE 689 561 2 6
LEVOTHYROXINE SODIUM 662 553 3 3
SIMVASTATIN 547 480 4 5
LISINOPRIL 487 436 5 2
OMEPRAZOLE 414 330 6 4
PRAVASTATIN SODIUM 373 323 7 17
POTASSIUM CHLORIDE 365 322 8 9
METFORMIN HCL 293 246 9 8
MELOXICAM 284 208 10 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 277 252 11 23
ZOLPIDEM TARTRATE 243 184 12 16
GABAPENTIN 243 164 12 10
PAROXETINE HCL 229 198 14 55
HYDROCHLOROTHIAZIDE 224 194 15 11
DONEPEZIL HCL 208 189 16 25
TAMSULOSIN HCL 193 178 17 28
ATORVASTATIN CALCIUM 181 132 18 15
NAMENDA 172 147 19 31
CLOZAPINE 172 122 19 181
TRAMADOL HCL 170 137 21 13
GLIMEPIRIDE 168 131 22 61
METOPROLOL SUCCINATE 165 129 23 20
AMLODIPINE BESYLATE 150 150 24 7
CARVEDILOL 142 125 25 21
POLYETHYLENE GLYCOL 3350 139 107 26 45
CITALOPRAM HBR 136 118 27 14
DIGOXIN 132 116 28 47
NEXIUM 130 83 29 26
EVISTA 126 123 30 148
ATENOLOL 126 98 30 22
WARFARIN SODIUM 124 119 32 19
METOPROLOL TARTRATE 123 98 33 12
ALENDRONATE SODIUM 123 122 33 35
MORPHINE SULFATE ER 119 34 S2 35 74
ALLOPURINOL 119 112 35 36
FENTANYL 114 84 S2 37 65
ADVAIR DISKUS 98 92 38 43
LOSARTAN POTASSIUM 98 90 38 34
PANTOPRAZOLE SODIUM 98 86 38 50
DICLOFENAC SODIUM 97 83 41 108
LOSARTAN-HYDROCHLOROTHIAZIDE 94 83 42 72
CYMBALTA 93 35 43 40
LANTUS 93 93 43 46
TRAZODONE HCL 91 30 45 32
CLOPIDOGREL 90 87 46 30
SERTRALINE HCL 89 84 47 24
DOXAZOSIN MESYLATE 88 77 48 87
CYCLOBENZAPRINE HCL 87 41 R 49 37
CARBIDOPA-LEVODOPA 87 78 49 101
FLUTICASONE PROPIONATE 83 70 51 27
PROAIR HFA 81 53 52 38
FENOFIBRATE 80 62 53 95
LYRICA 78 60 54 62
CRESTOR 77 57 55 33
CARISOPRODOL 75 26 R 56 54
MIRTAZAPINE 75 62 56 52
RANITIDINE HCL 74 63 58 29
ETODOLAC 73 53 59 137
ROPINIROLE HCL 73 46 59 68
IBUPROFEN 71 50 61 66
LOVASTATIN 69 64 62 41
MECLIZINE HCL 66 60 63 162
PROMETHAZINE HCL 66 20 R 63 69
JANUVIA 64 51 65 75
AMITRIPTYLINE HCL 63 55 R 66 64
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 56 66 71
EXELON 63 51 66 121
CLONIDINE HCL 62 43 69 42
ZETIA 62 38 69 109
FLUOXETINE HCL 61 30 71 44
DIVALPROEX SODIUM ER 61 34 71 171
FAMOTIDINE 58 39 73 77
AGGRENOX 58 54 73 182
ALPRAZOLAM 57 39 75 220
CELEBREX 56 42 76 81
CIPROFLOXACIN HCL 55 49 77 58
FINASTERIDE 55 45 77 115
SPIRIVA 54 44 79 53
PLAVIX 53 50 80 49
OXYCONTIN 52 23 S2 81 106
PREMARIN 52 28 R 81 90
VERAPAMIL ER 52 46 81 100
NOVOLOG MIX 70-30 51 42 84 338
MORPHINE SULFATE 51 17 S2 84 190
JANTOVEN 51 51 84 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.